BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36309415)

  • 21. Testosterone treatment for the aging man: the controversy.
    Morales A
    Curr Urol Rep; 2004 Dec; 5(6):472-7. PubMed ID: 15541218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-associated hypogonadism.
    Cohan GR
    AIDS Read; 2006 Jul; 16(7):341-5, 348, 352-4. PubMed ID: 16874913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC; Kirby RS
    Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone replacement in elderly men.
    Baum NH; Crespi CA
    Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Andropause].
    Hochreiter WW; Ackermann DK; Brütsch HP
    Ther Umsch; 2005 Dec; 62(12):821-6. PubMed ID: 16405287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. To treat or not to treat with testosterone replacement therapy: a contemporary review of management of late-onset hypogonadism and critical issues related to prostate cancer.
    Kava BR
    Curr Urol Rep; 2014 Jul; 15(7):422. PubMed ID: 24832199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.
    Lazarou S; Morgentaler A
    Curr Urol Rep; 2005 Nov; 6(6):476-81. PubMed ID: 16238923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the basis of sexual dysfunction during late-onset hypogonadism.
    Tharakan T; Miah S; Jayasena C; Minhas S
    F1000Res; 2019; 8():. PubMed ID: 30984376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
    Hassan J; Barkin J
    Can J Urol; 2016 Feb; 23(Suppl 1):20-30. PubMed ID: 26924592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Testosterone replacement therapy for hypogonadism in men with prostate cancer].
    Jensen CF; Fode M; Østergren P; Sønksen J
    Ugeskr Laeger; 2017 Feb; 179(9):. PubMed ID: 28263152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma?
    Landau D; Tsakok T; Aylwin S; Hughes S
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):179-81. PubMed ID: 21951017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of late-onset hypogonadism (andropause) treatment using three different formulations of injectable testosterone.
    Hohl A; Marques MO; Coral MH; Walz R
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):989-95. PubMed ID: 20126852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Male hormone replacement therapy including "andropause".
    Tenover JL
    Endocrinol Metab Clin North Am; 1998 Dec; 27(4):969-87, x. PubMed ID: 9922917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth].
    Rinnab L; Gust K; Hautmann RE; Küfer R
    Urologe A; 2009 May; 48(5):516-22. PubMed ID: 19296069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone.
    Chrysant SG; Chrysant GS
    Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone replacement therapy: clinical considerations.
    Luther PM; Spillers NJ; Talbot NC; Sinnathamby ES; Ellison D; Kelkar RA; Ahmadzadeh S; Shekoohi S; Kaye AD
    Expert Opin Pharmacother; 2024; 25(1):25-35. PubMed ID: 38229462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism.
    Santella C; Renoux C; Yin H; Yu OHY; Azoulay L
    Am J Epidemiol; 2019 Sep; 188(9):1666-1673. PubMed ID: 31145457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
    Kaplan AL; Lenis AT; Shah A; Rajfer J; Hu JC
    J Sex Med; 2015 Feb; 12(2):374-80. PubMed ID: 25496237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Testosterone supplementary therapy for type-2 diabetes mellitus males with hypogonadism: Controversy and analysis].
    Cheng Z; Zhang LY; Chen GM; He W; Cai K; Liao ZH
    Zhonghua Nan Ke Xue; 2017 Aug; 23(8):739-744. PubMed ID: 29726651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer: Testosterone therapy for hypogonadal men with prostate cancer.
    Catarinicchia SP; Crawford ED
    Nat Rev Urol; 2016 Sep; 13(9):497-8. PubMed ID: 27431338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.